nobel prize awarded for protein design and drug developments advance

The Nobel Prize in Chemistry has been awarded to David Baker, Demis Hassabis, and John Jumper for their contributions to computational protein design and structure prediction. Their work in protein folding has the potential to revolutionize drug development and therapeutic treatments.

Alnylam Pharmaceuticals' Application for Vutrisiran

Alnylam Pharmaceuticals has submitted an application to the FDA for the approval of vutrisiran, a drug used to treat nerve damage associated with transthyretin amyloidosis.

Johnson & Johnson Terminates Sunrise-2 Trial

Johnson & Johnson has terminated its Sunrise-2 trial for TAR-200, a drug delivery system for bladder cancer treatment, as it did not outperform traditional chemotherapy and radiation.

Gemma Biotherapeutics Partners with Fiocruz

Gemma Biotherapeutics has partnered with Brazil's Fiocruz to enhance the distribution of gene therapies for rare diseases in Brazil.

AstraZeneca Acquires Rights to Cholesterol-Lowering Drug

AstraZeneca has acquired the rights to a preclinical oral cholesterol-lowering drug targeting lipoprotein(a) from CPSC Pharmaceutical Group.

Astellas Secures Rights to Experimental Gene Therapy

Astellas has secured rights to an experimental gene therapy for frontotemporal dementia from AviadoBio.

These developments reflect the pharmaceutical industry's focus on innovative solutions to address complex health challenges.

Machinary offers a groundbreaking, modular, and customizable solution that provides advanced financial news and statistical analysis. Our platform goes beyond traditional quantitative analysis, offering users a comprehensive understanding of real-time market dynamics, event detection, and risk analysis.

Address

Waitlist

We’re granting exclusive early access to the first 500 users from december 20.

© 2024 by Machinary.com - Version: 1.0.0.0. All rights reserved

Layout

Color mode

Theme mode

Layout settings